Floatz logo

M-Sympathol

Carotid Stenosis

University Hospital, Clermont-FerrandSmall moleculePhase 4 / ApprovedDormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Carotid Stenosis cohort.

Asset / SponsorPhaseRating
Clopidogrel
Asan Medical Center
Phase 4BB
Atorvastatin
Columbia University
Phase 4BB
Ephedrine, Anhydrous
University Hospital, Clermont-Ferrand
Phase 4BB
Cilostazol
Asan Medical Center
Phase 4BB
Aspirin
Asan Medical Center
Phase 4BB

View all 25 →

Same molecule, other indications

M-Sympathol is also rated in:

hypotensive disorderDormant
BB
Indicative · Phase 4
69 / 100
View asset →
ischemic strokeActive
B
Indicative · Phase 3
56 / 100
View asset →
cognitive disorderDormant
B
Indicative · Phase 2/3
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →